WO2000055629A3 - Methods of diagnosing and treating breast cancer - Google Patents
Methods of diagnosing and treating breast cancer Download PDFInfo
- Publication number
- WO2000055629A3 WO2000055629A3 PCT/US2000/006952 US0006952W WO0055629A3 WO 2000055629 A3 WO2000055629 A3 WO 2000055629A3 US 0006952 W US0006952 W US 0006952W WO 0055629 A3 WO0055629 A3 WO 0055629A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- breast cancer
- diagnosing
- treating breast
- breast
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 206010006187 Breast cancer Diseases 0.000 title abstract 3
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 101100165224 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) BCH1 gene Proteins 0.000 abstract 1
- 239000012867 bioactive agent Substances 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA01009367A MXPA01009367A (en) | 1999-03-15 | 2000-03-15 | Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators. |
EP00916419A EP1159619A2 (en) | 1999-03-15 | 2000-03-15 | Methods of diagnosing and treating breast cancer |
CA002368152A CA2368152A1 (en) | 1999-03-15 | 2000-03-15 | Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators |
AU37527/00A AU3752700A (en) | 1999-03-15 | 2000-03-15 | Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators |
JP2000605210A JP2004537710A (en) | 1999-03-15 | 2000-03-15 | Novel methods and compositions for diagnosing and treating breast cancer and methods for selecting for breast cancer modulators |
US09/642,034 US6762020B1 (en) | 1999-03-15 | 2000-08-18 | Methods of diagnosing breast cancer |
US09/747,371 US6750013B2 (en) | 1999-12-02 | 2000-12-21 | Methods for detection and diagnosing of breast cancer |
US10/769,612 US20040141983A1 (en) | 1999-03-15 | 2004-01-29 | Compositions against cancer antigen LIV-1 and uses thereof |
US12/796,244 US8313745B2 (en) | 1999-03-15 | 2010-06-08 | Compositions against cancer antigen LIV-1 and uses thereof |
Applications Claiming Priority (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26886599A | 1999-03-15 | 1999-03-15 | |
US09/268,865 | 1999-03-15 | ||
US43987899A | 1999-11-12 | 1999-11-12 | |
US44037099A | 1999-11-12 | 1999-11-12 | |
US09/440,370 | 1999-11-12 | ||
US09/439,878 | 1999-11-12 | ||
US44049399A | 1999-11-15 | 1999-11-15 | |
US09/440,493 | 1999-11-15 | ||
US44067699A | 1999-11-16 | 1999-11-16 | |
US44067799A | 1999-11-16 | 1999-11-16 | |
US09/440,676 | 1999-11-16 | ||
US09/440,677 | 1999-11-16 | ||
US45081099A | 1999-11-29 | 1999-11-29 | |
US09/450,810 | 1999-11-29 | ||
US45313799A | 1999-12-02 | 1999-12-02 | |
US09/453,137 | 1999-12-02 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US52536100A Continuation-In-Part | 1999-03-15 | 2000-03-15 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US45313799A Continuation-In-Part | 1999-03-15 | 1999-12-02 | |
US09/642,034 Continuation-In-Part US6762020B1 (en) | 1999-03-15 | 2000-08-18 | Methods of diagnosing breast cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000055629A2 WO2000055629A2 (en) | 2000-09-21 |
WO2000055629A3 true WO2000055629A3 (en) | 2001-03-22 |
Family
ID=27575318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/006952 WO2000055629A2 (en) | 1999-03-15 | 2000-03-15 | Methods of diagnosing and treating breast cancer |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1159619A2 (en) |
AU (1) | AU3752700A (en) |
CA (1) | CA2368152A1 (en) |
WO (1) | WO2000055629A2 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1109937E (en) | 1998-09-02 | 2009-02-10 | Diadexus Inc | Method of diagnosing, monitoring, staging, and imaging various cancers |
US6902892B1 (en) | 1998-10-19 | 2005-06-07 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
US6962980B2 (en) | 1999-09-24 | 2005-11-08 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
US6468546B1 (en) | 1998-12-17 | 2002-10-22 | Corixa Corporation | Compositions and methods for therapy and diagnosis of ovarian cancer |
US7888477B2 (en) | 1998-12-17 | 2011-02-15 | Corixa Corporation | Ovarian cancer-associated antibodies and kits |
WO2001035811A2 (en) * | 1999-11-16 | 2001-05-25 | Eos Biotechnology, Inc. | Methods of diagnosing and determining prognosis of breast cancer |
EP1267934A4 (en) * | 1999-11-23 | 2004-03-17 | Diadexus Inc | A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
US7238471B1 (en) | 1999-11-23 | 2007-07-03 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating breast cancer |
CA2395832A1 (en) | 2000-01-25 | 2001-08-02 | Genentech, Inc. | Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
US7534417B2 (en) | 2000-02-24 | 2009-05-19 | Agensys, Inc. | 103P2D6: tissue specific protein highly expressed in various cancers |
GB0004576D0 (en) * | 2000-02-25 | 2000-04-19 | Oxford Glycosciences Uk Ltd | Proteins |
US20020102641A1 (en) * | 2000-03-24 | 2002-08-01 | Susan Schia Vi | Oncogenic osteomalacia-related gene 1 |
AU2001260309A1 (en) * | 2000-05-19 | 2001-12-03 | F.Hoffmann-La Roche Ag | A process for determining the tumoricidal potential of a sample by the use of a nucleic acid which is downregulated in human tumor cells |
US20030148920A1 (en) * | 2000-12-27 | 2003-08-07 | Steven Rosen | Sulfatases and methods of use thereof |
US20060063230A1 (en) | 2000-12-27 | 2006-03-23 | Roman Naworth | Sulfatases and methods of use thereof |
WO2002074906A2 (en) * | 2001-03-16 | 2002-09-26 | Eli Lilly And Company | Lp mammalian proteins; related reagents |
US6461847B1 (en) * | 2001-03-19 | 2002-10-08 | Applera Corporation | Polynucleotides encoding human estrone sulfatases |
CA2472163C (en) | 2001-12-31 | 2012-12-18 | Dana-Farber Cancer Institute, Inc. | Psoriasin expression by breast epithelial cells |
WO2003078662A1 (en) | 2002-03-13 | 2003-09-25 | Genomic Health | Gene expression profiling in biopsied tumor tissues |
CA2527571A1 (en) * | 2003-05-29 | 2004-12-09 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
EP1723428A2 (en) | 2004-02-19 | 2006-11-22 | Yale University Corporation | Identification of cancer protein biomarkers using proteomic techniques |
US20060063190A1 (en) * | 2004-09-22 | 2006-03-23 | Tripath Imaging, Inc | Methods and compositions for evaluating breast cancer prognosis |
US8093362B2 (en) | 2005-12-06 | 2012-01-10 | Kyowa Hakko Kirin Co., Ltd. | Anti-PERP recombinant antibody |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514554A (en) * | 1991-08-22 | 1996-05-07 | Becton Dickinson And Company | Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy |
WO1998018945A1 (en) * | 1996-10-31 | 1998-05-07 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
WO1998034118A1 (en) * | 1997-01-30 | 1998-08-06 | Yale University | Diagnostic methods and compositions based on the distribution of rad51 |
WO1999023230A1 (en) * | 1997-10-31 | 1999-05-14 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
WO1999025877A1 (en) * | 1997-11-18 | 1999-05-27 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
WO1999033869A2 (en) * | 1997-12-24 | 1999-07-08 | Corixa Corporation | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
WO2000008210A1 (en) * | 1998-08-04 | 2000-02-17 | Diadexus Llc | A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
-
2000
- 2000-03-15 AU AU37527/00A patent/AU3752700A/en not_active Abandoned
- 2000-03-15 CA CA002368152A patent/CA2368152A1/en not_active Abandoned
- 2000-03-15 EP EP00916419A patent/EP1159619A2/en not_active Withdrawn
- 2000-03-15 WO PCT/US2000/006952 patent/WO2000055629A2/en not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514554A (en) * | 1991-08-22 | 1996-05-07 | Becton Dickinson And Company | Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy |
WO1998018945A1 (en) * | 1996-10-31 | 1998-05-07 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
WO1998034118A1 (en) * | 1997-01-30 | 1998-08-06 | Yale University | Diagnostic methods and compositions based on the distribution of rad51 |
WO1999023230A1 (en) * | 1997-10-31 | 1999-05-14 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
WO1999025877A1 (en) * | 1997-11-18 | 1999-05-27 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
WO1999033869A2 (en) * | 1997-12-24 | 1999-07-08 | Corixa Corporation | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
WO2000008210A1 (en) * | 1998-08-04 | 2000-02-17 | Diadexus Llc | A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
Also Published As
Publication number | Publication date |
---|---|
EP1159619A2 (en) | 2001-12-05 |
AU3752700A (en) | 2000-10-04 |
CA2368152A1 (en) | 2000-09-21 |
WO2000055629A2 (en) | 2000-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000055629A3 (en) | Methods of diagnosing and treating breast cancer | |
WO2001031335A3 (en) | Cell proliferation diagnosis and screening for modulators | |
WO2000055633A3 (en) | Methods of screening for colorectal cancer modulators | |
WO2002021996A3 (en) | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators | |
MXPA03001389A (en) | Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies. | |
WO2004113571A3 (en) | Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis | |
WO2003042661A3 (en) | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer | |
IL127558A0 (en) | Hepatocyte growth factor receptor agonists and uses thereof | |
WO2002016413A3 (en) | Cripto tumour polypeptide | |
AU9312198A (en) | Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer | |
HK1050860A1 (en) | Nordihydroguaiaretic derivatives for use in treatment of tumors | |
WO2001011086A3 (en) | Methods of screening for angiogenesis modulators | |
WO2002055988A3 (en) | Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators | |
WO2002012328A3 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
WO1998045328A3 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
WO2004046332A3 (en) | Amplified genes involved in cancer | |
WO2001018046A3 (en) | Ovarian tumor sequences and methods of use therefor | |
AU2002338852A1 (en) | Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease | |
WO2002058534A3 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
WO2003013431A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
WO2002012280A3 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
WO2001090152A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
WO2002016939A3 (en) | Methods of diagnosis of cancer and screening for cancer modulators | |
WO2003026494A3 (en) | Galectins-1-and-4 in tumor development | |
WO2002059609A3 (en) | Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09747371 Country of ref document: US |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 605210 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/009367 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000916419 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2368152 Country of ref document: CA Ref country code: CA Ref document number: 2368152 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 2000916419 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000916419 Country of ref document: EP |